patient safety, we believe the unique nature of nuclear pharmacy and radiopharmaceuticals (e.g., due to the decay (self-limiting time) of these preparations, nearly all are given a BUD of less than 24 hours) warrants policies that allow for this critical practice area without affecting patient.